Li Xie
Impact in
- Oncology top 2%
- COVID-19 and healthcare impacts
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Beetle Biology and Toxicology Studies
Papers in
-
- Cancer-related molecular mechanisms research 11
- Cancer, Lipids, and Metabolism 7
- Cancer Genomics and Diagnostics 6
- Oncology 48
- Journals
- Tumor Biology (8 papers)PLoS ONE (6 papers)BMJ Open (5 papers)Cancer Causes & Control (4 papers)Cancer Medicine (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Xie
168 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Oncology 1.4k
- Cancer Research 734
- Infectious Diseases 570
- Pulmonary and Respiratory Medicine 568
- Hepatology 136
Countries citing papers authored by Li Xie
This map shows the geographic impact of Li Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Xie more than expected).
Fields of papers citing papers by Li Xie
This network shows the impact of papers produced by Li Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Xie. The network helps show where Li Xie may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 18 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 31 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 2 | |
| 12 | OSacc: Gene Expression-Based Survival Analysis Web Tool For Adrenocortical Carcinoma | 2019 | 1 |
| 13 | 2019 | 1 | |
| 14 | 2018 | 2 | |
| 15 | 2016 | 15 | |
| 16 | 2016 | 1 | |
| 17 | Effect of GSP on Enzyme Activity,Relative Weight of Internal Organs and Routine Blood Test for Weaned Piglets | 2012 | 8 |
| 18 | microRNA:A new cancer biomarker | 2010 | 1 |
| 19 | 2009 | 0 | |
| 20 | Study of Drawing and Recognizing Particle Appearance | 2000 | 2 |
About Li Xie
Li Xie is a scholar working on Cancer Research, Oncology, Obstetrics and Gynecology, Hepatology and Otorhinolaryngology, having authored 180 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Liver Disease Diagnosis and Treatment (8 papers), Cancer, Lipids, and Metabolism (7 papers), Genetic factors in colorectal cancer (7 papers), Cancer Genomics and Diagnostics (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Hepatitis B Virus Studies (6 papers) and Traumatic Brain Injury and Neurovascular Disturbances (6 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (734 citations), Infectious Diseases (570 citations), Pulmonary and Respiratory Medicine (568 citations) and Hepatology (136 citations). Li Xie has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xue Qin, Taijie Li, Shan Li, Yanqiong Liu, Qiliu Peng, Qinxin Shen, Shuyun Xu, Peng Li, Fangfang Zhu and Peipei Zhang. Their work appears in journals such as Tumor Biology, PLoS ONE, BMJ Open, Cancer Causes & Control and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.